CU Anschutz Clinical Trial Shows Fewer Heavy Drinking Days PR Newswire AURORA, Colo., July 29, 2026 A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
Coping with Anxiety Coping with anxiety involves several preparatory steps and strategies aimed at reducing stress and managing symptoms
Some research suggests that caffeine may have modest metabolic benefits , though these are small and short-lived
Our approach is personalized, supportive, and grounded in science
Lab Testing Head to any Quest Diagnostics Lab to complete your lab testing
For example, in 2012, a compounded steroid medication that was contaminated with a fungus was administered to patients throughout the country, resulting in over 750 patients contracting fungal infections and more than 60 deaths